ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
E

EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy for NDMM Patients

By ecancer FEATURING Elias Mai
By ecancer FEATURING Elias Mai
93 views
June 21, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn
EHA 2022
04:46
ecancer

Phase II Expansion Results: Glofitamab Induces Durable Complete Remi…

Feat. M. Dickinson
03:35
ecancer

EHA 2022: Quizartinib Improves OS in Adults With FLT3-ITD+ AML

Feat. H. Erba
06:01
ecancer

EHA 2022: Ponatinib & Blinatumomab for Patients With Ph+ ALL

Feat. N. Short
07:31
ecancer

EHA 2022 on CLIMB THAL-111 and CLIMB SCD-121 Studies: Single-Dose ct…

Feat. F. Locatelli
03:54
ecancer

EHA 2022 on a Bispecific Antibody Talquetamab in R/R MM: Safety &…

Feat. M. Minnema
05:24
ecancer

EHA 2022 CARTBCMA-HCB-01 Study Updates: A Novel CAR T-Cell Therapy T…

Feat. C. Fernandez De Larrea
03:44
ecancer

EHA 2022 on R-CODOX-M/R-IVAC vs. Dose-Adjusted EPOCH-R in Newly Diag…

Feat. M. Chamuleau
04:51
ecancer

EHA 2022 on Targeted Therapy Combinations With Venetoclax Superior t…

Feat. B. Eichhorst
04:29
ecancer

EHA 2022 Time-Limited Venetoclax-Obinutuzumab +/- Ibrutinib Surpasse…

Feat. B. Eichhorst
03:35
ecancer

EHA 2022 on the Efficacy & Safety of ARI0002H, a BCMA-Directed C…

Feat. C. Fernandez De Larrea
04:29
ecancer

EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy…

Feat. E. Mai
02:19
ecancer

Lecture Summary - EHA 2022: Lenalidomide, Bortezomib, and Dexamethas…

Feat. P. Richardson